Literature DB >> 31325559

Evidence that melatonin downregulates Nedd4-1 E3 ligase and its role in cellular survival.

Esra Yalcin1, Mustafa C Beker1, Seyma Turkseven2, Berrak Caglayan3, Busra Gurel4, Ulkan Kilic5, Ahmet B Caglayan6, Rabia Kalkan5, Ahmet T Baykal4, Taha Kelestemur1, Ertugrul Kilic7.   

Abstract

Indolamine melatonin structurally resembles non-covalent proteasome inhibitors; however, the role of ubiquitin proteasome system (UPS) in neuronal survival and how melatonin carries out UPS inhibition remain largely unknown. With the use of melatonin treated cells, we evaluated the expression of Nedd4-1, an E3 ligase, how melatonin regulates its activity and its relationship with neuronal survival. Nedd4-1 was upregulated in the hypoxic condition in both control and Nedd4-1 overexpressed cells and melatonin treatment reversed its expression in both normoxic and hypoxic conditions, which was associated with increased cellular survival. Melatonin had no effect on the expression of Nedd4-1 at mRNA level. However, when melatonin was administered along with protein synthesis inhibitor cycloheximide, protein level of Nedd4-1 was further reduced, indicating that melatonin possibly downregulates Nedd4-1 after its synthesis. Notably, co-immunoprecipitation analyses followed by Liquid chromatography-Mass Spectrometry (LC-MS/MS) revealed that melatonin may dissociate ribosomal proteins, such as RS19, RL23A, and nucleophosmin from Nedd4-1, while 40S ribosomal protein S7 and 60S ribosomal protein L35 came into contact with Nedd4-1 upon melatonin treatment. By using IPA analyses, we obtained further data indicated novel target molecules of melatonin in hypoxic conditions, including OTOF, SF3B2, IPO5, ST13, FGFR3, Mx1/Mx2, playing roles in RNA splicing and trafficking, growth factor and interferon signaling. Here, we described a new insight into the role of melatonin in UPS functioning by proposing a molecular mechanism through which melatonin regulates Nedd4-1.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Melatonin; Nedd4-1; Proteasome; Proteomic; Ubiquitin; Ubiquitin proteosome system

Mesh:

Substances:

Year:  2019        PMID: 31325559     DOI: 10.1016/j.taap.2019.114686

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  5 in total

1.  Phosphodiesterase 10A Is a Critical Target for Neuroprotection in a Mouse Model of Ischemic Stroke.

Authors:  Mustafa C Beker; Ahmet B Caglayan; Serdar Altunay; Elif Ozbay; Nilay Ates; Taha Kelestemur; Berrak Caglayan; Ulkan Kilic; Thorsten R Doeppner; Dirk M Hermann; Ertugrul Kilic
Journal:  Mol Neurobiol       Date:  2021-11-04       Impact factor: 5.590

2.  Interpretable machine learning identifies paediatric Systemic Lupus Erythematosus subtypes based on gene expression data.

Authors:  Jennifer R S Meadows; Jan Komorowski; Sara A Yones; Alva Annett; Patricia Stoll; Klev Diamanti; Linda Holmfeldt; Carl Fredrik Barrenäs
Journal:  Sci Rep       Date:  2022-05-06       Impact factor: 4.996

Review 3.  SARS-CoV-2 and other coronaviruses negatively influence mitochondrial quality control: beneficial effects of melatonin.

Authors:  Saeed Mehrzadi; Mohammad Yahya Karimi; Alireza Fatemi; Russel J Reiter; Azam Hosseinzadeh
Journal:  Pharmacol Ther       Date:  2021-03-01       Impact factor: 13.400

Review 4.  The regulatory roles of the E3 ubiquitin ligase NEDD4 family in DNA damage response.

Authors:  Xinxin Lu; Haiqi Xu; Jiaqi Xu; Saien Lu; Shilong You; Xinyue Huang; Naijin Zhang; Lijun Zhang
Journal:  Front Physiol       Date:  2022-08-26       Impact factor: 4.755

5.  Interaction of melatonin and Bmal1 in the regulation of PI3K/AKT pathway components and cellular survival.

Authors:  Mustafa C Beker; Berrak Caglayan; Ahmet B Caglayan; Taha Kelestemur; Esra Yalcin; Aysun Caglayan; Ulkan Kilic; Ahmet T Baykal; Russel J Reiter; Ertugrul Kilic
Journal:  Sci Rep       Date:  2019-12-13       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.